Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2007, Vol. 03 ›› Issue (04): 202 -f7. doi: 10.3877/cma.j.issn.1673-5250.2007.04.107

Original Article

Construction of recombinant adenovirus containing cytosine deaminase gene driven by human telomerase reverse transcriptase promoter

Shu-hua HUANG, Zhi-lan PENG, He WANG   

  1. Hexian Memorial Hospital of Panyu, Panyu 511400, Guangzhou, China
  • Published:2007-08-01
Objective

To construct recombinant adenovirus vectors in which the cytosine deaminase (CD) gene is under the control of the human telomerase reverse transcriptase (hTERT) promoter.

Methods

Recombined adenovirus of Ad-hTERTp-CD was constructed using homologous recombination in cells by transforming shuttle vector pSU-Tp-CD and adenovirus backbone vector pBHGE3 into 293 cells.

Results

Recombinant adenovirus vectors were confirmed by PCR analysis and DNA sequencing.

Conclusion

Replication-defective adenovirus vector in which the CD gene was driven by hTERT promoter was made successfully.

图1 12号克隆酶切鉴定
图2 PCR扩增CD基因序列
图3 PCR扩增hTERT启动子序列
1 Umeoka T,Kawashima T,Kagawa S,et al. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene. Cancer Res, 2004,64(17):6259-6265.
2 Song JS, Kim HP. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line. Oncol Rep, 2004,12(2) :443-447.
3 Nakamura M,Kyo S,Kanaya T,et al. hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin. Cancer Gene Ther,2004,11(1):1-7.
4 Kawashima T,Kagawa S,Kobayashi N, et al. Telomerase-specific replication-selective viro therapy for human cancer. Clin Cancer Res, 2004,10(1 Pt l):285-292.
5 Irving J,Wang Z,Powell S,et al. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. Cancer Gene Ther,2004,11(3):174-185.
6 Boyd M,Mairs RJ, Keith WN, et al. An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radio astatine and harnessing radiation-mediated by stander effects. J Gene Med,2004,6(8) :937-947.
7 Wirth T,Kuhnel F,Kubicka S. Telomerase-dependent gene therapy. Curr Mol Med,2005,5(2): 243-251.
8 Bett AJ, Haddara W, Prevec L, et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA, 1994,91(19) :8802-8806.
[1] Shu-hua HUANG, Zhi-lan PENG, He WANG, Xiao-yun CHEN, Wei-qiang FENG. Selective Killing Effect of Cytosine Deaminase Gene Controlled by Human Telomerase Reverse Transcriptase Promoter on Cervical Cancer Cells[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2010, 06(03): 172-174.
Viewed
Full text


Abstract